Oxford Nanopore Technologies plc has named its replacement chair for the retiring Peter Allen.
Duncan Tatton-Brown will join the MedTech company on 1st August 2022, with Allen retiring from the board on the previous day.
Tatton-Brown served as CFO at Ocado plc from 2012-2020, growing it from a pure-play online grocer into a global technology business.
He has extensive experience as an executive and non-executive director of FTSE companies, growth and founder-led businesses across technology, retail and media. He remains a senior advisor to Ocado and currently also serves on the boards of Cazoo and Trainline.
Oxford Nanopore floated on the London Stock Exchange last year in a £3.4 billion IPO priced at 425 pence per share. Its current share price stands at 284p.
The firm, spun out of Professor Hagan Bayley’s University of Oxford lab, has developed a real-time DNA/RNA sequencer and can assist with accurate, rapid testing in cancer and infectious disease.
Oxford Nanopore’s sequencing devices are being used in scientific research worldwide, and increasingly in regulated environments such as healthcare and food safety.
The company serves thousands of customers across a wide range of scientific communities, in more than 100 countries around the world.
“Duncan brings substantial board experience of supporting high-tech growth technology companies, critical to our long-term ambition of enabling the analysis of anything, by anyone, anywhere,” said CEO Gordon Sanghera.
“I would like to thank Peter for his support and guidance over the years and very much look forward to working with Duncan as we enter the next phase of growth.”
Tatton-Brown added: “The company has already achieved a huge amount, and yet is in the foothills of its growth journey. The future opportunities for its sensing technology are immense, from the current scientific research community to future uses across health, agriculture, food or environmental applications.
“This potential is underpinned by its highly innovative and differentiated technology, fantastic team, strong business model and growing customer base. I look forward to working with the board and the executive team to ensure the ongoing and long-term success of Oxford Nanopore.”